Flt-1 Monoclonal Antibody

This gene encodes a member of the vascular endothelial growth factor receptor (VEGFR) family. VEGFR family members are receptor tyrosine kinases (RTKs) which contain an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and a tyrosine kinase (TK) domain within the cytoplasmic domain. This protein binds to VEGFR-A, VEGFR-B and placental growth factor and plays an important role in angiogenesis and vasculogenesis. Expression of this receptor is found in vascular endothelial cells, placental trophoblast cells and peripheral blood monocytes. Multiple transcript variants encoding different isoforms have been found for this gene. Isoforms include a full-length transmembrane receptor isoform and shortened, soluble isoforms. The soluble isoforms are associated with the onset of pre-eclampsia.

The FLT-1 Monoclonal Antibody is a cutting-edge product that has been meticulously developed to cater to the needs of the scientific community. This antibody, derived from a single clone, exhibits exceptional specificity and sensitivity, making it an invaluable tool for various research applications.

The FLT-1 Monoclonal Antibody is designed to target and bind to the FLT-1 receptor, a crucial protein involved in angiogenesis and vascular development. Its high affinity ensures reliable and accurate detection of FLT-1, enabling researchers to gain deeper insights into the intricate mechanisms underlying these processes.

With its exceptional performance, this antibody offers a wide range of applications, including immunohistochemistry, immunofluorescence, and Western blotting. Its versatility allows for precise localization and quantification of FLT-1 expression in various tissue types, facilitating comprehensive analysis and interpretation of experimental results.

Furthermore, the FLT-1 Monoclonal Antibody has undergone rigorous quality control measures to ensure consistency and reproducibility. Its formulation guarantees stability and long shelf life, providing researchers with a reliable and durable reagent for their studies.

In summary, the FLT-1 Monoclonal Antibody is a state-of-the-art product that combines exceptional specificity, sensitivity, and versatility. Its reliable performance and meticulous design make it an indispensable tool for scientists and researchers seeking to unravel the complexities of angiogenesis and vascular development.